Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$7.54 USD
-0.14 (-1.82%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $7.52 -0.02 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Solid Biosciences Inc. - Hold
Zacks' proprietary data indicates that Solid Biosciences Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the SLDB shares relative to the market in the next few months. In addition, Solid Biosciences Inc. has a VGM Score of F (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Solid Biosciences Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of SLDB, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.